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Abstract.  The myristoylated form of c-Abl protein,  as 
well as the P21&  cr/*t protein,  have been shown by in- 
direct immunofluorescence to associate with F-actin 
stress fibers in fibroblasts. Analysis of deletion mu- 
tants of c-Abl stably expressed in fibroblasts maps the 
domain responsible for this interaction to the extreme 
COOH-terminus of Abl.  This domain mediates the as- 
sociation of a heterologous protein with F-actin fila- 
ments after microinjection into NIH 3T3  cells, and 
directly binds to F-actin in a cosedimentation assay. 
Microinjection and cosedimentation assays localize the 
actin-binding domain to a 58 amino acid region,  in- 
cluding a charged motif at the extreme COOH- 
terminus  that is important  for efficient binding.  F-actin 
binding by Abl is calcium independent,  and Abl com- 
petes with gelsolin for binding to F-actin.  In addition 
to the F-actin binding dornain,  the COOH-terminus of 
Abl contains a proline-rich region that mediates bind- 
ing and sequestration of G-actin,  and the Abl F- and 
G-actin binding domains cooperate to bundle F-actin 
filaments in vitro.  The COOH terminus of Abl thus 
confers several novel localizing functions upon the 
protein,  including actin binding,  nuclear localization, 
and DNA binding.  Abl may modify and receive sig- 
nals from the F-actin cytoskeleton in vivo, and is an 
ideal candidate to mediate signal transduction  from the 
cell surface and cytoskeleton to the nucleus. 
I 
T has  long  been appreciated  that  there  is  an  intimate 
connection between the cytoskeleton, cell growth, mor- 
phology, and the process of transformation.  In the trans- 
formed state,  fibroblasts  and epithelial  cells exhibit  several 
morphological  alterations  including  increased  membrane 
ruffling, increased cell motility, increased saturation density, 
and loss of contact inhibition.  This is accompanied by a dra- 
matic reorganization  of elements  of the cytoskeleton, with 
loss of F-actin stress fibers, depolymerization of F-actin, and 
loss of focal adhesions.  These alterations are associated with 
changes in cellular actin-binding  proteins,  such as the actin 
severing protein gelsolin  (Vandekerckhove et al.,  1990). 
Transmembrane  tyrosine  kinases,  such  as  the  PDGF 
receptor,  indirectly  influence the response of the cytoskele- 
ton to growth factor stimulation by activating members of the 
Ras family of small  G proteins,  p21 rho has  been shown to 
induce  formation  of new stress  fibers  and focal adhesions 
(Ridley and Hall,  1992), while the related ms family mem- 
ber p21 ~c serves to induce membrane ruffling and reorgani- 
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zation of the cortical actin network (Ridley et al., 1992), al- 
though  the  precise effectors  of these  G  proteins  are  not 
known.  Similar  signal transduction  pathways, leading  from 
receptor tyrosine kinase activation to G proteins,  have been 
implicated by genetic studies of Caenorhabditis elegans vul- 
val development  (Horvitz and  Sternberg,  1991) and  Dro- 
sophila retinal  development  (Simon et al.,  1993). 
Non-receptor tyrosine kinases,  typified  by the src gene 
product,  have  been  shown  to  interact  directly  with  the 
cytoskeleton, v-Src protein induces  a dramatic  reorganiza- 
tion of the cytoskeleton of chick embryo fibroblasts, an effect 
which occurs after temperature  shift  with a  temperature- 
sensitive  allele  of v-Src,  v-Src is found in focal adhesions 
(Rohrschneider,  1980) and a fraction of the protein is mem- 
brane  associated,  the  latter  interaction  directed  by  the 
myristate group  and  NH2-terminal  amino  acid  sequences 
(Krueger et al.,  1982; Kaplan et al.,  1990).  Several com- 
ponents of adhesion plaques are tyrosine phosphorylated in 
v-Src-transformed cells, although none of the substrates has 
been shown to be essential for transformation  (Kamps et al., 
1986).  However,  tyrosine phosphorylation of integrins  in 
adhesion  plaques  of normal  fibroblasts  has  been demon- 
strated (Hynes, 1992), and the effect of tyrosine phosphatase 
inhibitors  on cell morphology strongly  suggests an impor- 
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morphology (Klarlund, 1985). 
Abl is a non-receptor protein-tyrosine kinase whose large 
COOH-terminal domain distinguishes it from members of 
the src family. Activated forms of Abl, typified by the viral 
transforming protein pl60g,s,v~% transform both fibroblasts 
and hematopoietic ceils, and are localized to the cytoplasm, 
plasma membrane,  and focal adhesions,  similarly to  Src 
(Rohrschneider and Najita,  1984;  Van Etten et al.,  1989). 
Another activated form of Abl, the P210  ~c'/~t protein of hu- 
man chronic myelogenous leukemia, is also localized to the 
cytoplasm, and is associated with F-actin microfilaments in 
fibroblasts,  hematopoietic cells, and epithelial cells (Wetzler 
et al., 1993; Daley et al., 1992; McWhirter and Wang, 1991; 
McWhirter and Wang,  1993).  The normal cellular Abl pro- 
tein, c-Abl, is present in two forms which differ at their ex- 
treme NH2 termini. The type IV/Ib protein is myristoylated 
on the NH2-terminal glycine, while the type I/Ia protein is 
not. Neither protein can transform fibroblasts or hematopoi- 
etic cells, even upon overexpression (Jackson and Baltimore, 
1989). The subcellular localization of the type IV c-Abl pro- 
tein was determined in NIH 3T3  cells overexpressing the 
protein, and it was found to be largely nuclear, although ap- 
preciable amounts were found associated with the plasma 
membrane and in the cytoplasm (Van Etten et al., 1989). In 
addition, there was a prominent association of c-Abl  with 
filamentous cytoplasmic structures resembling F-actin stress 
fibers. 
Here  we  show  that  these  structures  indeed  represent 
F-actin microfilaments, and map the domain of  Abl responsi- 
ble for this interaction to the extreme COOH terminus of 
Abl.  This  domain binds  directly  to  F-actin  in  vitro.  A 
subregion of this domain, distinct from the F-actin binding 
site,  binds to the monomeric form of actin, G-actin.  To- 
gether, the Abl F- and G-actin binding domains mediate bun- 
dling of F-actin in vitro. 
Materials and Methods 
Abl Expression Constructs and Mutants 
For stable expression of Abl proteins in NIH 3T3 cells, the retroviral expres- 
sion vector pPL was used (Jackson  and Baltimore,  1989).  NIH 31"3 cell 
lines stably expressing  mutant Abl proteins were generated by calcium 
phosphate eo-transfeetion  with pSV2neo, and screening clones for expres- 
sion by indirect intrnunofluorescence.  The expression of  the mutant proteins 
was confirmed in all cases by immunoblotting of cell extracts with anti-Abl 
antisera (data not shown).  The construction and expression of pPLcIV, 
pPLclVAXB, and pPLclVAPH was previously described (Jackson and Bal- 
timore, 1989). The mutant pPLclVQ5 was generated by purifying the 4.1-kb 
EeoRI-HindlII fragment from pJ3elVQ5 (Jackson and Baltimore,  1989) and 
ligating into the polylinker site of pPL. pPI.,clV K290M was generated by 
site-specific  mutagenesis  utilizing the dut/ung phagemid system (Bio-Rad 
Laboratories, Beverly, MA), as described (Mayer et al.,  1992).  pPLclV 
K290MASal,  pPLclV K290MABgl, and pPLcIV K290MATth were gener- 
ated by digestion of pPLclV K290M with Sail, BglI, or Tthlll-I, respec- 
tively.  A  synthetic  oligonucleotide  containing an  in-frame  termination 
codon was ligated to the Sail-digested  pPLclV K290M DNA, truncating 
the  COOH-terrninal  160  amino  acids  of Abl.  BgllI-digested  pPLclV 
K290M DNA was blunted with the Klenow fragment of Escherichia  coli 
DNA polymerase I, ligeted to a 14-mer SpeI linker containing termination 
codons in all three reading  frames,  digested  with SpeI and self-ligeted. 
Tthlll-I-digested pPLclV K290M  was  blunted with Klenow  fragment, 
ligated to Bell linkers, digested with Bell and self-ligated.  The insertion of 
the BclI linker results in the generation of a TGA termination codon after 
isoleucine at position 1139, truncating the three COOH-terrninal amino 
acids of Abl. All mutations were confirmed by DNA sequencing. 
GST-Abl Fusion Proteins and Gelsolin $2-3 Domain 
Portions  of the Abl sequence,  including  the pEX5 COOH-terminal se- 
quence,  were expressed  in E. coli as fusion proteins with the Schistosoma 
japonicum glutathione S-transferase  (GST) 1 using the Glutagene system 
(Pharmacia, Piscataway, NJ) and purified by affinity chromatography on 
glutathione-agarose  beads (Molecular Probes, Eugene,  OR) as described 
(Van Etten et al.,  1989).  For production of NH2-terminal  deleted fusion 
proteins AFok,  ASca, AHinf,  and ABgl, the 1.1-kb SaiI-HindHI  insert of 
pEXS/pGEX-I was digested with Fold, ScaI, Hint, or BglII, and restriction 
fragments of 530, 916, 806, or 710 bp isolated, respectively. The FOkI, ScaI, 
and Hint fragments were blunted with Klenow fragment and cloned into 
the Sinai site of the appropriate pGEX vector, while the BgUI fragment was 
cloned into the BamHI site of pGEX-3X. The COOH-terminai deleted fu- 
sion protein ASca(C)  was produced by cloning the 205-bp BamHI/SCaI 
fragment from pEXS/pGEX-1  back  into pGEX-1. The junction of the 
GST-Abl reading frame was verified in each case by DNA sequencing,  and 
chimeric nature of the GST-Ahl fusion proteins confirmed by immunoblot- 
ting bacterial cell extracts with anti-pEX5  antisera (data not shown).  The 
GST-gelsolin fusion protein was generated by cloning the eDNA of the gel- 
solin $2-3 domain (kind gift of Dr.  M. Way, Whitehead Institute,  Cam- 
bridge, MA) into the pGEX-2T vector and purifying the 54-kD fusion pro- 
tein on glutathione-agerose beads.  After elution from the beads,  fusion 
proteins were desalted by chromatography on Sephedex  G-25 in 50 mM 
NH4HCO3, pH 7.8, followed by lyophilization.  In general, final fusion pro- 
tein preparations were 80--95% full-length protein, with small amounts of 
shorter species which did not interfere with the pelleting or microinjection 
assays. 
Where indicated, fusion proteins expressed in the pGEX-2T vector and 
containing the thromhin cleavage site were cleaved by incubation with 1.0% 
(wt/wt) human thromhin (Caibiochem-Novabiochem  Corp., La JoUa, CA) 
as described (Mayer et al., 1992; Smith and Corcoran, 1992) for 2 h at room 
temperature in the presence of 2.5 mM CaCl2. Free GST and uncleaved fu- 
sion protein was removed by adsorption with glutathione-agarose beads, 
and the purified Abl protein was desalted by chromatography on Sephadex 
G-25 and concentrated by lyophilization. 
The gelsolin $2-3 domain, containing the F-actin binding domain, was 
expressed  as a 28-kD protein in E.  coli using the pET vector system and 
BL21(DE3)  host strain (Studier  et al.,  1990) (kind gift of Dr.  M. Way, 
Whitehead Institute)  essentially  as described (Way et al., 1992). The final 
preparation was greater than 95% intact $2-3 protein on SDS-PAGE, and 
copelleted with F-aetin with an estimated binding constant of about 1-5 #M 
(data not shown), consistent with previous observations  (Way et al., 1992). 
Cell Culture and Microinjection 
NIH 3T3 cell lines were maintained in DME with 10% calf serum at 37°C 
in a humidified 5% CO2 atmosphere.  Cells were plated onto acid-washed 
glass coverslips at concentrations of 0.5-1.0  x  104 cells/era 2 48 h before in- 
jection. Fusion proteins were resuspended in 1 mM Tris-aeetate  (pH 7.0) 
at 2.5-5.0 mg/ml, and introduced into cells by microinjection as described 
(Graessman et al.,  1980) using a Zeiss Axiophot inverted phase contrast 
microscope.  For each fusion protein, 30-50 cells were injected,  and the av- 
erage injection volume was about 2-5% of cell volume.  1 h after injection, 
cells were fixed and extracted  with 4% paraformaldehyde  (EM Sciences, 
Gibhstown, NJ) in 1× PHEM buffer, pH 6.1, with 0.1% Triton X-100 for 
5 rain at 37°C as described (Sehliwa and van Blerkom, 1981). Detection 
of fusion protein was with affinity-purified rabbit antisera directed against 
GST used at 2 pg/rnl, while secondary antibody was donkey  anti-rabbit 
IgG,  Texas red-conjugated (Jackson  ImmunoResearch Labs Inc.,  West 
Grove, PA), at 15/~g/ml.  Detection of F-aetin was with FITC-eonjugated 
phailoidin (Molecular Probes) used at a concentration of 6.7 U/ml (,~0.22 
ttM) in PBS.  After washing,  coverslips  were  mounted in Fluoromount 
(Fisher Scientific Co., Pittsburgh, PA) and photographed on a Zeiss epifluo- 
rescence microscope  with Kodak T-Max ASA 400 black and white film. 
Immunofluorescence 
Cells were plated onto glass eoverslips at a density of 1-2  ×  104 cells/cm  2. 
In some cases,  coverslips  were precoated with bovine fibronectin (Sigma 
Immunochemicals,  St. Louis, MO) at 5 ttg/ral. For routine staining of Abl, 
cells were fixed in absolute methanol for 5 rain followed by acetone for 2 
rain, both at -20°C. For double immunofluorescence  staining of Abl and 
1. Abbreviations used in this paper: GAP, GTPase-activating  protein; GST, 
gluthione S-transferase;  SH3,  Src homology  type 3. 
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method of Small et al. (1978).  Following fixation, cells were blocked with 
5 % normal donkey serum in PBS. For staining of  Abl, the primary antibody 
was affinity-purified rabbit anti-pEX4 sera (Van Etten et al., 1989) at 1-5 
/~g/mi, with secondary antibody and phalloidin staining as described above. 
Actm 
Rabbit skeletal muscle actin was purified as described (Spudich and Watt, 
1971) with gel filtration as a  final step (MacLean-Fletcher and Pollard, 
1980).  Actin was labeled with pyrene iodoacetamide as previously de- 
scribed (Kouyama and Mihashi, 1981). NBD-labeled G-actin (Detmers et 
al., 1981) was kindly provided by Ralph Gieselmann (Brigham and Women's 
Hospital, Boston, MA). G-actin solutions contained 2 mM Tris, pH 7.6, 0.2 
mM CaCI2,  0.2 mM DTT,  0.5 mM ATE 
F-actin Pelleting Assays 
Actin pelleting assays were done according to the method of Matsudalra 
(1992),  using an Optima TLX microultracentrifuge and TL-100.1  rotor 
(Beckman Instruments, Palo Alto, CA). Equal amounts of starting material, 
supernatant, and pellet were solubilized in loading buffer, boiled, and sub- 
jeered to SDS-PAGE on 5-18%  gradient Laemmli gels (Matsudalra and 
Burgess, 1978). Gels were stained with Coomassie blue, dried between cel- 
lophane, and protein bands quantitated by densitometric scanning, utilizing 
a  MicroTek MSF-300GS  image scanner and Aldus Superpaint software 
(Silicon Beach). Protein concentration was determined by the Bio-Rad pro- 
tein assay reagent in comparison to a standard BSA curve. Dye binding by 
the fusion proteins was linear in the range used. In the case of the pEX5 
fusion protein (which comigrates with actin at about 42 kD), the proteins 
were transferred to nitrocellulose after electrophoresis, and immunoblotted 
with afffinity-purified anti-pEX5 antibodies. The primary antibody was de- 
tected with t25I-labeled protein A (kind gift of Dr. Lloyd Klickstein, Cen- 
ter for Blood Research, Boston, MA). 
For in vitro transcription, the c-abl (IV) and c-abl (IV) AXB cDNAs 
were cloned into the pGEM-4 vector (Promega Biotec, Madison, WI), 
DNA templates linearized by cutting with HindIII or SalI, and RNA tran- 
scribed with SP6 RNA polymerase (Promega Biotec) to yield m_RNA cod- 
ing for Abl protein which is full length or lacking the COOH-terminal 165 
amino acids,  respectively. Rabbit  reticulocyte lysates (Promega Biotec) 
were programmed with the appropriate abl RNA, Abl proteins labeled with 
[35S]methionine  (Dupont/New England Nuclear,  Boston,  MA),  and ali- 
quots used for cosedimentation with F-actin as described above. Following 
SDS-PAGE,  3SS-labeled  Abl  proteins  were  visualized  by  fluorography 
utilizing Amplify solution (Amersham Corp., Arlington Heights, IL). 
To determine the calcium dependence of actin binding by Abl, pelleting 
was performed with the addition of 0.2 mM CaCl2 to the assay buffer.  For 
Scatchard analysis, r/c was plotted versus c, where r  =  (moles of GST-Abl 
bound to F-actin)/(moles of F-actin pelleted) and c  =  concentration of un- 
bound GST-Abl.  To investigate whether Abl and gelsolin compete for the 
same binding site on F-actin, GST-AFOk and gelsolin $2-3 were simultane- 
ously mixed with F-actin before pelleting. The molar ratio of AFOk to actin 
was kept constant at 2.0, while the molar ratio of gelsolin to actin was varied 
over a range of  0.0 to 2.0. Equivalent amounts of supernatant and pellet frac- 
tions were analyzed by SDS-PAGE, and quantitation of fusion protein bind- 
ing was performed as described above. 
Fluorescence Assays of  Actin Polymerization 
The rate and extent of actin polymerization in the presence of various Abl 
proteins were determined from the increase in fluorescence of pyrene-actin 
that occurs when pyrene-labeled actin polymerizes, as described (Kouyama 
and Mihashi, 1981).  Polymerization of actin was initiated by mixing 198 
#1 of G-actin in buffer A (2 mM Tris-HC1,  pH 8.0, 0.2 mM CaC12, 0.2 mM 
DTT,  0.5 mM ATP) with 30 #1 of solutions containing Abl protein in 10 
mM Tris, pH 7.4,  and then adding 12 #1 of 40 mM MgCI2 and 3M KC1 
to raise the Mg  2+ and KC1 concentrations to 2 mM and 150 mM, respec- 
tively.  The total pyrine-actin concentration was 3/zM. 
Native Gel Electrophoresis 
Native gel electrophoresis was performed essentially as described by Safer 
(1989).  Purified monomeric G-actin (1-3  #g) was mixed with a  one- to 
threefold molar excess of purified GST-Abl  or  Abl protein in buffer G 
(2 mM Pipes, pH 7.0, 0.2 mM CaCI2, 0.2 mM DTT, 0.2 mM ATP) and in- 
cubated on ice for 30 min.  Glycerol was added to  10%  and the sample 
loaded on a 6% polyacrylamide (30:0.8  acrylamide/bis) gel containing 25 
mM Tris,  194 mM glycine, 0.5 mM CaCle, 0.2 mM DTT,  and 0.2 mM 
ATP. Gels were prerun in the same buffer for 1 h at 4°C at 200 V, and fresh 
buffer  added  before  loading  samples.  The  proteins  were  detected by 
Coomassie blue staining. In this assay, when G-actin is mixed with a protein 
with G-actin binding activity, there is a shift of actin from the original posi- 
tion in the gel to a new position of lower electrophoretic mobility, represent- 
ing formation of a complex between the two proteins (Safer,  1989). 
Light Scattering 
The intensity of light scattered at 90 ° during and after polymerization of 
actin was measured with a Brookhaven Instruments BI30ATN  instrument 
and a  10 mW He-Ne laser. The reaction conditions were the same as used 
for fluorescence measurements. 
Electron Microscopy 
3 #M F-actin samples were applied to Formvar-coated copper grids, nega- 
tively stained with 1% uranyl acetate, and visualized with a JEOL 1200-EX 
transmission electron microscope at an accelerating voltage of 80 kV. 
Results 
Abl Associates with F-actin Stress l~bers In Vivo via a 
COOH-terminal Domain 
The myristoylated  form of murine c-AN was stably expressed 
in NIH 3T3 fibroblasts. Double immunofluorescence stain- 
ing with fluorescein-conjugated phalloidin, which specifi- 
cally binds to F-actin microfilaments, demonstrates that Abl 
associates with F-actin stress fbers (Fig. 1 A). The associa- 
tion is punctate along the entire length of the microfilament, 
and there is no obvious preference for ends of filaments or 
adhesion plaques. In addition, Abl continues to co-localize 
with F-actin after treatment of cells with cytochalasin D, 
a  drug  which  disrupts  F-actin  into  small  fragments and 
induces a  major reorganization of the  cytoskeleton (data 
not shown). 
We analyzed several mutant forms of Abl for actin associa- 
tion.  Although Src homology type 3  (SH3) domains have 
been identified in several actin-binding proteins, deletion of 
the Abl SH3 domain had no effect on actin association (data 
not shown). In contrast, Abl proteins which were truncated 
at the COOH terminus, typified by the mutant cIV K290M 
ASal (Fig. 1, B and C) lacked detectable F-actin association, 
implicating the 165 COOH-terminal amino acids of Abl in 
actin  association.  Truncation  of the  COOH-terminal  32 
amino acids of Abl in the mutant cIV K290M ABgl also 
resulted in the complete lack of detectable F-actin associa- 
tion (Fig. 1, B and C). Abl was also truncated at the extreme 
COOH terminus at a unique Tthll M site, resulting in the de- 
letion of the three COOH-terminal amino acids (VRR). This 
mutant, cIV K290M ATth, demonstrated greatly reduced 
actin-association in vivo, although residual weak co-staining 
of  actin microfilaments was detectable in all clones examined 
(Fig.  1, B and C). This suggests  that the extreme COOH- 
terminal 32 amino acids of Abl are required for association 
of the protein with F-actin in vivo, and the COOH-terminal 
VRR sequence is important, though not absolutely required. 
The COOH-terminal Domain of  Abl Associates 
with F-actin after Microinjection, and Directly Binds 
to F-actin in a Cosedimentation Assay 
The COOH-terminal 165 amino acids of Abl, denoted pEX5 
for historical reasons (Konopka et al., 1984), was expressed 
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Figure 1.  (A) Co-localization of Abl with F-actin stress filaments in NIH 3T3 fibroblasts stably expressing c-Abl (IV). Cells were fixed 
with glutaraldehyde and Triton X-100 (Small et al., 1978). (a) Primary antibody is afffinity-purified  rabbit t~-pEX4 antibodies, secondary 
antibody is Texas red-conjugated  donkey anti-rabbit IgG.  (b) Same field as in a,  visualized to detect FITC-phalloidin staining. (B) 
Schematic representation of COOH-terminal truncation mutants of c-Abl (IV). The myristoylation site, SH3 domain, kinase domain, and 
pentalysine nuclear localization signal are indicated. All mutants contain a kinase-inactivating point mutation in the ATP-binding site of 
the Abl tyrosine kinase domain (K290M), which improves expression without affecting actin association. (C) Indirect immunofluorescence 
of NIH 3T3 cell lines stably expressing COOH-terrninal truncation mutants of c-Abl, using afffinity-purified  anti-pEX4 antibodies. Cells 
were fixed  with methanol and acetone. (a) c-Abl (IV) K290M; (b) c-Abl (IV) K290M ASal; (c) c-Abl (IV) K290M ABgl; (d) c-Abl (IV) 
K290M ATth. Bar, 10/zm. 
in E.  coli as a fusion protein with GST and microinjected 
into  NIH  3T3  fibroblasts.  The GST-pEX5  fusion protein 
demonstrated  prominent  association  with  F-actin  stress 
fibers one hour after injection (Fig. 2 a), as did a fusion pro- 
tein of GST with the F-actin binding domain of gelsolin (Fig. 
2 b). By contrast, cells injected with the GST protein alone 
showed only a diffuse cytoplasmic and perinuclear staining 
without detectable association with microfilaments (Fig. 2 
c). Interestingly, a GST-SH3 fusion protein, containing 89 
amino acids spanning the Abl SH3 domain fused to GST, 
failed to associate with the major F-actin stress fibers after 
microinjection, but did appear to associate with the very ter- 
minal portion of F-actin cytoskeleton just proximal to the 
lamellipodia of the cell (Fig. 2 d). Thus, the pEX5 domain 
of Abl contains determinants which can direct the associa- 
tion of heterologous proteins with actin microfilaments, and 
the Abl SH3 domain, while not capable of association with 
large F-actin stress fibers, does have some affinity for the ter- 
minal F-actin network. 
To confirm the microinjection results, GST fusion proteins 
were tested for in vitro binding to F-actin in a cosedimenta- 
tion assay (Matsudaira,  1992). A mixture of Abl and F-actin 
was pelleted by ultracentrifugation, and the amount of  bound 
Abl detected by SDS-PAGE of supernatant and pellet frac- 
tions.  A  significant amount of GST-pEX5  fusion protein 
cosediments with F-actin (Fig. 3 a), where none of  the paren- 
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tal GST protein cosediments (Fig. 3 b). The GST-SH3 fusion 
protein exhibited no significant cosedimentation with F-actin 
(Fig. 3 c), confirming previous observations (Cicchetti et al., 
1992), despite the weak association with the terminal Foactin 
cytoskeleton observed after microinjection.  To investigate 
whether the native  c-Abl protein also binds to F-actin,  we 
performed  actin  cosedimentation  assays  with  3sS-labeled 
Abl proteins generated by in vitro translation.  A large frac- 
tion of  the full-length type IV c-Abl protein cosediments with 
F-actin,  while Abl protein which lacks the COOH-terminal 
165 amino acids shows greatly reduced but still significant 
actin  cosedimentation  (Fig.  3  d).  Therefore,  the COOH- 
terminal domain of Abl accounts for the majority of the Abl 
actin-binding  activity, but other sequences in Abl appear to 
play a lesser but significant role.  When the SH3 domain is 
deleted  from  the  type  IV  c-Abl,  the  resulting  protein, 
denoted c-Abl (IV) AXB (Jackson and Baltimore,  1989), still 
exhibits prominent cosedimentation with F-actin which is re- 
duced to background levels when the COOH-terminal do- 
main is also deleted (Fig.  3 e). Thus,  in the context of the 
entire Abl protein, the COOH-terminal domain accounts for 
the majority of the actin-binding  activity, with the SH3 do- 
main contributing  at a lower but significant  level. 
Further Mapping of the Abl F-actin Binding Domain 
To better define the Abl F-actin binding  site, the pEX5 do- 
main  was sequentially  deleted from the NH2- and  COOH- 
terminal  sides and the corresponding GST fusion proteins 
assayed for F-actin binding  by microinjection  and pelleting 
(Figs.  4 and 5).  The fusion protein GST-AFok (containing 
c-Abl  type IV  amino  acids  1015-1142) retains  prominent 
F-actin association after microinjection (Fig. 5 a). The GST- 
ASca protein exhibits weaker but clearly discernible associa- 
tion with F-actin  (Fig. 5 b). The fusion protein GST-AHinf 
retains  some F-actin association,  but also exhibits a promi- 
nent association  with small linear  structures  at the ventral 
surface of the cell, suggestive of focal adhesions  (Fig. 5 c). 
The identity of  these structures was confirmed by double im- 
munofluorescence  with an anti-talin  monoclonal  antibody, 
and by reflection interference  microscopy (data not shown). 
However, the fusion protein GST-ABgl lost all association 
with F-actin after microinjection  (Fig. 5 d). Fusion proteins 
truncated at the Tthl 11-I or HinfI sites were insoluble and 
unable to be used in the assay, but a larger COOH-terminal 
truncation  protein,  GST-pEX5/ASca(C),  was  soluble and 
also  showed  no  detectable association  with  F-actin  after 
microinjection  (Fig.  5 e). These data suggest that  the Abl 
F-actin  association  domain lies in the COOH-terminal 58 
amino acids. 
As a complement to further mapping the actin-binding do- 
main by microinjection, the same series of NH2- and COOH- 
terminal deleted fusion proteins were assessed for their abil- 
ity to cosediment with F-actin (Fig. 4). The AFok, ASca, and 
AHinf fusion proteins retained the ability to bind to F-actin, 
although quantitatively less of  the GST-ASca and GST-AHinf 
Van Etten et al.  c-Abl Actin Binding Domain  329 Figure 2. Micminjection of GST fusion proteins into NIH 3T3 cells. (Lejt) Primary antibody is aflinity-pudfied rabbit anti-GST antibodies, 
secondary antibody is Texas red-conjugated donkey anti-rabbit IgG. (Right) Same feld stained with FITC-phaUoidin. (a) GST-pEXS; (b) 
GST-gelsolin $2-3.  (c) GST. (d) GST-SH3.  (a was photographed at higher magnification than b-d).  Bars,  10/xm. 
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longer fusion proteins GST-pEX5 and GST-AFok. By con- 
trast,  the GST-ABgl and the GST-ASca(C) fusion proteins 
showed  no  co-pelleting.  Thus,  Abl/F-actin  association  in 
vivo, after microinjection, and in vitro all appear to require 
the extreme 58 COOH-terminal amino acids of the Abl pEX5 
domain. In both microinjection and pelleting assays, binding 
of  this domain to F-actin appears to be strengthened by inclu- 
sion  of  NH2-terminal  pEX5  sequences  present  in  GST- 
pEX5 and GST-AFok. 
Gelsolin Competes with Abl  for Binding to F-actin 
Increasing amounts  of the  GST-AFok fusion protein were 
copelleted with F-actin and amount of Abl fusion protein in 
supernatant and pellet fractions quantitated by densitometry 
(Fig. 6 A). Scatchard analysis (Fig. 6 B) indicated a binding 
constant of about  18 t~M for the GST-Abl/F-actin interac- 
tion, significant but somewhat weaker than the affinity of the 
$2-3  domain  of gelsolin  for  F-actin  (Way  et  al.,  1992). 
Pelleting of GST-AFok with Foactin in the presence of 0.2 
mM EGTA or 0.2 mM CaC12 revealed no obvious change 
Figure 3.  Actin cosedimentation  assay. (a-c) Cosedimentation  of 
GST-Abl  fusion  proteins.  Each  GST-Abl  fusion  protein  was 
cosedimented  with F-actin at 0.25, 1.0, or 2.5-fold  molar excess 
with respect to actin, while a sample at the highest concentration 
(2.5-A) was centrifuged without actin. Equivalent amounts of start- 
ing material (T), supernatant (S), and pellet (P) were fractionated 
by SDS-PAGE. Dot indicates position of actin, arrowhead indicates 
position of GST-Abl. (a) GST-pEX5; (b) GST; (c) GST-SH3; (d-e) 
Cosedimentation  of  in  vitro  translated  Abl  proteins.  Rabbit 
reticulocyte lysates containing 35S-labeled Abl protein which was 
either full-length (FL) or lacking the COOH-terminal  165 amino 
acids (ASal) were cosedimented with F-actin, while identical sam- 
pies were centrifuged without actin (-A). Equivalent amounts of 
starting material (T), supernatant (S), and pellet (P) were fraction- 
ated by SDS-PAGE and Abl proteins visualized by fluorography. By 
Coomassie blue staining, more than 95 % of the actin was found in 
the pellet fraction in each case (data not shown). (d) c-Abl (IV); 
(e) c-Abl (IV) with internal SH3 deletion (AXB). Arrowheads indi- 
cate positions of Abl proteins. 
Figure 4. Schematic represen- 
tation of GST-Abl fusion pro- 
teins  and  summary of GST- 
Abl  actin-interaction  assays. 
Abl sequences only are repre- 
sented; all species contain an 
NH2  terminal  26-kD  GST 
moiety. Numbers  correspond 
to amino  acids  from murine 
type IV c-Abl (Ben-Neriah et 
al.,  1986). The asterisk  indi- 
cates that the GST-AHinf fu- 
sion protein had an increased 
affinity  to  localize  at  focal 
adhesions  after  microinjec- 
tion.  (ND, not determined). 
Van Etten et al. c-Abl Actin Binding Domain  331 Figure 6. (,4) Quantitation of binding of GST-AFok fusion protein 
to F-actin by cosedimentation. Equivalent amounts of supernatant 
(S) and pellet (P) were fraetionated by SDS-PAGE.  A denotes posi- 
tion of actin, F denotes GST-AFok. Lane 7, no actin added; lanes 
1-6, increasing amounts of GST-AFok protein added to F-actin, 
from 0.2- to 3.0-fold molar excess with respect to actin. (B) Scatch- 
ard analysis of data derived from A.  (C)  Gelsolin $2-3  domain 
competes with GST-AFok for binding to F-actin. A twofold molar 
excess  of  GST-AFok  over  F-actin  was  used,  with  increasing 
amounts of $2-3 polypeptide.  Equivalent amounts of supernatant 
(S) and pellet (P) were fractionated by SDS-PAGE. A indicates the 
position of actin, F indicates the position of GST-AFok, and S indi- 
cates the position of $2-3.  Lane 1, no $2-3 added;  lanes 2-7, in- 
creasing amounts of $2-3, from 0.2 to 2.0 molar equivalents with 
respect to actin; lane 8, GST-AFok without actin; lane 9, $2-3 with- 
out actin. 
in the affinity of Abl for F-actin (data not shown).  When in- 
creasing amounts of purified gelsolin $2-3  were added to a 
mixture  of GST-AFok  and  F-actin,  the  $2-3  was  able  to 
efficiently and completely compete with  the GST-AFok for 
pelleting, suggesting that Abl and gelsolin bind to the F-actin 
microfilament via the same or overlapping binding sites (Fig. 
6 C, lanes 2-7). $2-3 competed efficiently with Abl for bind- 
ing to F-actin even at fairly low concentrations (for example, 
see  Fig.  6  C,  lane  4),  confirming  that  it  has  significantly 
higher  affinity for actin than  Abl does. 
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Figure 7. Inhibition of pyrene-actin polymerization by a subregion 
of the  Abl actin-binding  domain.  Actin  was polymerized in  the 
presence of the indicated Abl protein,  and the rate and extent of 
F-actin formation followed  by fluorimetry. (A) Initial polymeriza- 
tion rates of 3 ttM actin in the presence of 3/~M GST-Abl fusion 
protein or purified pEX5. (Inset) Final fluorescence values of the 
experiment in A,  which  correlates  with  the  steady-state level of 
F-actin. The data for GST-ASca(C) was derived from separate ex- 
periments,  and  the  values were converted to the  same scale by 
normalization  to  control  reactions  containing  actin  alone.  (B) 
Effect of increasing amounts of purified pEX5 polypeptide on poly- 
merization of 3/~M pyrene-actin. (InseO Plot of the final fluores- 
cence versus the concentration of Abl for GST-pEX5 and purified 
pEXS. 
The Abl pEX5 Region Contains a Distinct G-actin 
Binding Domain 
We tested  the effect of adding  purified Abl  fusion proteins 
to actin labeled with the fluorescent tag N-(1-pyrenyl) iodo- 
acetamide, also known as pyrene-actin, and examined the ki- 
netics of polymerization of the labeled actin by fluorimetry. 
At concentrations less than that of actin,  the GST-pEX5 fu- 
sion protein  showed no evidence of nucleation,  capping or 
Figure 5. Microinjection of NH2-  and COOH-terminal deleted GST-Abl fusion proteins into NIH 3T3 cells. Same orientation as in Fig. 
2. (a) GST-AFok; (b) GST-ASca; (c) GST-AHinf; (d) GST-ABgl; arrow indicates staining of focal adhesions; (e) GST-,~Sca(C).  Bar,  10 #m. 
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equimolar ratios to actin, Abl strongly suppressed the rate 
(Fig. 7 A) and extent (Fig. 7 A, inset) of pyrene-actin poly- 
merization. We were concerned that these effects might be 
due to binding of Abl to newly polymerized F-actin with 
blocking of polymerization at the barbed end, but the GST- 
ASca(C) fusion protein, which lacks the F-actin binding do- 
main, also inhibits pyrene-actin polymerization (Fig. 7 A). 
These effects were not observed with the parental GST pro- 
tein,  nor  with  the  NH2-terminal  deleted  fusion  proteins 
GST-AFok  and  GST-AHinf.  The  increased  fluorescence 
caused by the GST-AFok  protein does not appear to be nucle- 
ation because the lag time before fluorescence rise is not 
eliminated,  but  may  rather  result  from fluorescence en- 
hancement of the pyrene probe caused by this protein bind- 
ing to the side of the filament. 
To show that the inhibition of pyrene-actin polymerization 
is  not  dependent  on  the  GST  sequences  present  in  the 
GST-pEX5 fusion protein, we cleaved the GST moiety from 
the fusion protein utilizing human thrombin (Smith and Cor- 
coran,  1992),  removed  free  GST  by  binding  to  GSH- 
agarose, and used the purified pEX5 polypeptide in the py- 
rene-actin assay.  The purified pEX5 protein alone exhibits 
a more potent and near stoichiometric inhibitory effect on 
the rate of actin polymerization (Fig. 7 B) and on the final 
fluorescence of the pyrene-actin (Fig. 7 B, inset). No effect 
on actin polymerization was observed with purified AFok 
polypeptide alone (data  not shown).  Further,  the pyrene- 
labeled G-actin can be displaced from pEX5 and polymer- 
ized by adding an excess of unlabeled G-actin at the end of 
the initial polymerization reaction (data not shown). This be- 
havior  is  consistent  with  binding  and  sequestration  of 
G-actin monomers by Abl,  and suggests that the NH2-ter- 
minal 40 amino acids of the pEX5 region contains a G-actin 
binding domain (Fig. 4). 
To directly confirm that Abl binds to G-actin,  we em- 
ployed a  different assay for G-actin binding,  native acryl- 
amide gel electrophoresis. G-actin alone forms a single dis- 
crete band on native gels (Fig. 8 A, lane 5). The GST-pEX5 
fusion protein migrates as a series of diffuse bands, possibly 
representing oligomerization of the protein (Fig.  8 A, lane 
3), When a twofold molar excess of the GST-pEX5 fusion 
protein is mixed with G-actin, there is a significant decrease 
in the amount of actin migrating at the position of mono- 
meric G-actin, without the appearance of an obvious new 
band of lower mobility (Fig. 8 A, lane 4). No decrease is ob- 
served when the parental GST protein or the GST-AFok pro- 
tein is mixed with G-actin (Fig. 8 A, lanes 6 and 8, respec- 
tively), confirming that the NH2-terminal 40 amino acids of 
the pEX5 region are responsible for this effect. In contrast, 
the GST-ASca(C) fusion protein, which contains the NH2- 
terminal portion of the pEX5 region but lacks the F-actin 
binding domain, has a marked effect, decreasing the amount 
of actin migrating as monomeric G-actin by >90%  (Fig.  8 
A, lane 2). To determine where the remainder of the G-actin 
is migrating, we performed the assay utilizing G-actin cova- 
lently labeled with rhodamine, and detected labeled actin af- 
ter electrophoresis by observing the gel under short wave 
ultraviolet light (Safer, 1989). The remainder of the G-actin 
was found at the very top of the gel after addition of GST- 
pEX5 or GST-ASca(C) fusion protein, suggesting the forma- 
tion of an Abl/G-actin complex which was either insoluble 
or very large (data not shown). 
The presence of GST sequences is not required for this 
effect, because purified pEX5 polypeptide alone has a dra- 
matic and stoichiometric effect on G-actin, eliminating es- 
sentially  100%  of monomeric  G-actin  as  the  amount  of 
pEX5 added exceeds equimolar levels (Fig. 8 B, lanes 1-4). 
In  contrast,  purified  AFok  polypeptide lacking  GST  se- 
quences has no effect on migration of G-actin (Fig. 8 B, lanes 
6--9). When rhodamine-actin is used with purified pEX5, the 
actin is again found at the top of the gel (data not shown). 
The actin is not simply degraded, because the two proteins 
are found to be intact after incubation if a portion of the mix- 
ture is boiled and electrophoresed on a  denaturing SDS- 
polyacrylamide gel (data not shown).  These data confirm 
that the pEX5 region contains a G-actin binding domain in 
NH2-terminal 40 amino acids of the region. G-actin bind- 
Figure 8. Native gel electrophoresis assay for G-actin binding by 
Abl. 3/zg actin was used in all samples, so that the amount of  mono- 
meric G-actin may be directly compared between lanes. (A) GST- 
Abl fusion proteins.  Lane 1, GST-ASca(C) alone; lane 2,  GST- 
ASca(C) +  G-actin; lane 3, GST-pEX5 alone; lane 4, GST-pEX5 
+  G-actin; lane 5, G-actin alone; lane 6, GST-AFok +  G-actin; 
lane  7, GST-AFok alone;  lane 8, GST +  G-actin; lane 9, GST 
alone. (B) Purified pEX5 and purified AFok polypeptides. Lanes 
1-4, increasing amounts of pEX5, ranging from 0.5 to 2.0 molar 
excess with respect to actin.  Lanes 6-9,  increasing amounts of 
AFok,  ranging from 0.5 to 2.0 molar  excess. Lanes 5  and 10, 
G-actin alone. The purified Abl polypeptides migrate as diffuse 
species of lower mobility and are not shown; the position of mono- 
merle G-actin is indicated by the arrows. 
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Figure 9. Effect of GST-pEX5 and other GST-Abl fusion proteins 
on light scattering by polymerizing actin. 3 ~M unlabeled actin was 
polymerized in the presence of the indicated amount of GST fusion 
protein. (B) Final level of light scattering induced by various Abl 
proteins. GST-AFok, GST-ABgl,  and GST-ASca(C)  were present at 
3 ~M. 
ing by Abl was not dependent on calcium because no differ- 
ence was observed when CaC12 was omitted from the bind- 
ing buffer and  gel  and  2  mM  EGTA included  (data  not 
shown). However, the pEX5 domain was observed to bind 
significantly more efficiently to G-actin which had ADP as 
the bound nucleotide (Laham et al.,  1993) than with ATP- 
actin (data not shown). 
For some proteins, binding of G-actin may be detected by 
a change in the fluorescence emission spectrum of actin la- 
beled with pyrene or NBD (Lee et al.,  1988). There was no 
significant change  in  the  fluorescence spectrum of either 
pyrene-  or  NBD-labeled  actin  after  addition  of purified 
pEX5 (data not shown), suggesting that Abl does not interact 
with Cys 374 of actin, the site of attachment of the fluores- 
cent label. 
The Abl F- and G-actin Binding Domains Mediate 
Bundling of F-actin 
We also examined the effect of adding purified Abl fusion 
proteins on light scattering by polymerizing actin. The GST- 
pEX5  fusion  protein,  when  present  at  nearly  equimolar 
amounts relative to actin, greatly increased the rate and ex- 
tent of the increase in light scattering that accompanies actin 
polymerization (Fig. 9, A and B). This result demonstrates 
that the GST-pEX5 fusion protein binds to F-actin and in- 
creases the size of the solute after actin polymerization, pos- 
sibly by promoting the formation of actin filament bundles. 
This effect is not seen with the parental GST protein, with 
a GST-S2-3 fusion protein, or with actin alone, nor is it ob- 
served with any of the shorter GST-Abl fusion proteins such 
as GST-AFok and GST-ASca(C). 
Binding of F-actin by GST fusion proteins may be compli- 
cated by the fact that GST forms dimers (Ji et al., 1992; Par- 
ker et al.,  1990). Therefore, a single actin-binding site that 
would not link two filaments together by itself might cross- 
link F-actin when expressed as a dimer of GST-fusion pro- 
teins. To show that the effects of GST-pEX5 on light scatter- 
ing were not related to the presence of GST in the fusion 
protein, we cleaved the pEX5 domain from GST sequences 
by  thrombin,  and  found  that  purified  pEX5  polypeptide 
alone had  a  near-stoichiometric effect on light  scattering 
(Fig. 9 B). 
To demonstrate directly that the increased light scatter- 
ing  was  due  to  filament bundle  formation,  we  examined 
Abl/F-actin  complexes by  transmission  electron micros- 
copy.  GST-pEX5/F-actin preparations  showed  prominent 
crosslinking of F-actin filaments into loose bundles (Fig. 10 
A).  Similar bundling  activity was  detected when purified 
pEX5 protein was used alone (Fig.  10 C), but no bundles 
were detected with actin alone (Fig.  10 D), with GST (Fig. 
10 B),  or with GST-zIFok or GST-S2-3 (data not shown). 
There was no obvious decoration of the filament with either 
pEX5 or AFok. The F-actin bundling activity thus appears 
to require both the F- and G-actin binding domains to be 
present.  In addition,  a  1:1  mixture of the GST-AFok and 
GST-ASca(C) fusion proteins was unable to bundle F-actin 
(data not shown). This confirms that two distinct domains of 
Abl are required for bundling, and these domains must be 
present in cis on the same polypeptide in order for filament 
bundling to occur. 
We  wished  to  determine  whether  the  Abl  G-actin  se- 
questering activity or the F-actin binding/bundling activity 
would predominate under in vitro conditions. Pyrene-actin 
was allowed to polymerize to equilibrium, and an equimolar 
amount of Abl protein added. The mixture was then diluted 
50-fold so that the concentration of G-actin was below the 
critical concentration, and the depolymerization of F-actin 
followed by fluorimetry. The GST-pEX5 protein significantly 
retarded the depolymerization of F-actin, while GST-AFok 
and GST proteins had no effect on the depolymerization rate 
(data not shown). This suggests that bundling by pEX5 stabi- 
lizes F-actin, and sequestration of G-actin by pEX5 does not 
accelerate  the  depolymerization.  Binding  of  GST-AFok 
without bundling did not stabilize the F-actin.  Therefore, 
Abl appears to promote the assembly rather than disassem- 
bly of actin under these in vitro conditions. 
Discussion 
We have shown that the c-Abl tyrosine kinase possesses dis- 
tinct F- and G-actin binding domains in the COOH terminus 
of the protein, that the protein associates with the F-actin 
Van Etten et al. c-Abl Actin Binding  Domain  335 Figure 10. EM photomicrographs of Abl-actin complexes negatively stained with uranyl acetate. All samples contained 3 #M F-actin and 
equimolar amounts of GST or Abl proteins. (A) GST-pEX5; (B) GST alone; (C) purified pEXS; (D) actin alone. 
cytoskeleton in  fibroblasts,  and the two actin-binding do- 
mains  cooperate to bundle F-actin in vitro.  These results 
raise the possibility that Abl could both modulate the state 
of the actin cytoskeleton in vitro and transduce signals from 
the cytoskeleton to the nucleus. 
Abl F-actin Binding Domain 
The Abl F-actin binding domain has been mapped to the ex- 
treme COOH terminus of the protein. The association of Abl 
with F-actin is observed with several different fixation condi- 
tions  including  methanol/acetone,  paraformaldehyde,  and 
glutaraldehyde, making it unlikely to be an artifact of fixa- 
tion.  All  experiments were performed on NIH  3T3  cells 
which  expressed Abl  from a  retroviral expression vector 
(Jackson and Baltimore, 1989), and overexpressed the pro- 
tein  3-10-fold over the level of endogenous Abl proteins. 
With improved affinity-purified antisera, we have been able 
to detect endogenous nuclear Abl protein by immunofluores- 
cence of NIH  3T3  cells  (Van  Etten,  R.,  unpublished  re- 
sults), but have not yet been able to detect staining of mi- 
crofilaments.  Further  improvements  in  immune  reagents 
may allow the detection of this association in cells not over- 
expressing Abl. 
The F-actin binding domain of murine c-Abl has also been 
localized to the COOH terminus by transient expression of 
mutant  Abl proteins  in  Cos  cells  (McWhirter and  Wang, 
1993).  In our experiments, the COOH-terminal 58 amino 
acids of the Abl protein are sufficient to allow binding of Abl 
to F-actin with a particular affinity for focal adhesions, an 
effect also  observed  in  Cos  cells  with  expression of the 
COOH-terminal 32 amino acids of Abl joined to sequences 
from the first exon of Bcr and the Abl SH3/SH2 domains. 
However, the GST-ABgl fusion protein, which contains only 
the 32 COOH-terminal amino acids of Abl, showed no de- 
tectable F-actin association in microinjection and pelleting 
assays.  It is possible that inclusion of Bcr sequences in the 
Abl polypeptide may strengthen the Abl/F-actin interaction 
(McWhirter and Wang,  1991) and allow the detection of  weak 
residual  F-actin  binding  activity  present  in  the  COOH- 
terminal 32 amino acids of Abl. This might be partly due to 
the ability of Bcr to self-associate (Campbell et al.,  1990). 
With regards to the COOH-terminal boundary of the F-actin 
binding domain, deletion of  the three C OOH-terminal amino 
acids  abolished  F-actin  association  by  Abl  in  Cos  cells 
(McWhirter and Wang,  1993). Expression of the cIV ATth 
mutant in NIH 3T3 fibroblasts shows that this protein has 
greatly reduced but detectable association with  actin mi- 
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residues are not absolutely required for F-actin binding. 
SH3 domains have been identified in a number of actin- 
binding proteins of  diverse origin, including certain isoforms 
of myosin H  (Jung et al.,  1987),  the cytoskeletal protein 
a-spectrin  (wasenius  et  al.,  1989),  and  the  yeast actin- 
binding protein ABP-1 (Drubin et al., 1990). However, in no 
case has an SH3 domain been directly implicated in actin 
binding, and actin lacks the proline-rich consensus sequence 
which has been identified as an SH3-binding motif (Ren et 
al.,  1993).  In Abl, the SH3 domain does not appear to ac- 
count for the majority of the actin-association observed by 
immunofluorescence. Deletion of the  entire  SH3  domain 
yields a protein which still exhibits prominent association 
with F-actin, while truncation of Abl at the extreme COOH 
terminus abolishes detectable actin co-staining.  However, 
the Abl SH3 domain does associate with the terminal F-actin 
network after microinjection, and we have observed that Abl 
mutants with large COOH-terminal truncations, which lack 
nuclear localization signals and are totally cytoplasmic, also 
weakly co-localize with peripheral F-actin in vivo (Van Etten, 
R., unpublished results). In addition, the SH3 domains of 
phospholipase C-  7  and GRB-2 associate with F-actin mi- 
crofilaments and membrane ruffles, respectively, after mi- 
croinjection (Bar-Sagi et al., 1993). In the context of  the full- 
length Abl protein, the SH3 domain contributes a minor but 
significant fraction of the total actin-binding activity in co- 
sedimentation experiments, but the isolated Abl SH3 domain 
exhibits no significant cosedimentation with F-actin.  The 
affinity of the isolated SH3 domain for actin may be too low 
to be detected by cosedimentation, but may be increased by 
the presence of other Abl sequences.  Alternately, the Abl 
SH3 domain may associate with F-actin indirectly by inter- 
acting with other actin-binding proteins, some of which may 
be present in reticulocyte lysates. These data suggest that 
SH3 domains do mediate some level of association of signal- 
ing proteins with the cytoskeleton, and the combination of 
the SH3 domain and the COOH-terminal F-actin binding do- 
main may modulate the distribution of Abl within the cyto- 
skeleton. 
When the Abl COOH-terminal sequence is compared with 
available  sequences  in  nucleic acid and protein sequence 
databases,  no significant similarities are  identified except 
with other Abl family members, including the abl-2 or arg 
gene (Kruh et al., 1990).  There are similarities between the 
COOH terminus of Abl and human dystrophin, and between 
Abl and myosin E-heavy chain, but these occur in different 
portions of the Abl sequence and do not involve the actin- 
binding domains of  these proteins. There is a weak similarity 
between the extreme COOH terminus of Abl and a repeated 
domain  found  in  several  actin-binding  proteins  such  as 
a-actinin, dystrophin, ~spectrin, and the homologous pro- 
teins chicken fimbrin, human L-plastin, and yeast Sac6p, all 
of which  terminate  in  the  motif aaXR,  where  a  is  an 
aliaphatic amino acid (Adams et al.,  1991; McWhirter and 
Wang,  1993).  However,  Abl lacks most of the other con- 
served residues shared by these proteins, including a trypto- 
phan which is absolutely conserved. Thus, the significance 
of this similarity is unknown. The aaXR motif  at the extreme 
COOH terminus appears to be important, because trunca- 
tion  of the  COOH-terminal  VRR  sequence  from mouse 
c-Abl reduces but does not eliminate F-actin binding in vivo. 
However, this truncation may have a large effect on the con- 
formation of the COOH-terminal domain of Abl, because it 
causes the corresponding GST-Abl fusion protein to become 
unstable and insoluble. Although the c-Abl ATth mutant was 
expressed at reasonable levels  in vivo, the reduced F-actin 
association may be a consequence of altered conformation 
rather  than  loss  of residues  directly  involved in  F-actin 
binding. 
It is apparent that actin-binding domains of different actin- 
binding proteins can be similar in their functional and bind- 
ing characteristics without sharing significant homology at 
the amino acid level (Way et al.,  1992).  From competition 
pelleting experiments, the F-actin binding domains of gelso- 
lin, et-actinin, and dystrophin appear to bind to the same do- 
main on the F-actin microfilament (way et al., 1992; Hem- 
mings et al.,  1992).  Because the gelsolin $2-3  domain and 
the Abl F-actin binding domain also compete for binding to 
F-actin but neither binds G-actin, they may recognize a com- 
mon  determinant  formed  by  the  junction  of  two  actin 
monomers in the filament, despite the lack of any conserved 
amino  acid  sequences  between  the  two  proteins.  It  has 
proven difficult to precisely define actin-binding domains 
through the generation and assay of point mutations (way et 
al., 1992). It may be possible to better define the Abl actin- 
binding domain by a mutagenesis strategy using phage dis- 
play technology, and by obtaining structural  information 
from NMR or crystallographic analyses. 
Abl G-actin Binding Domain and Bundling Activity 
The distinct G-actin binding domain of Abl was discovered 
through a dramatic and specific effect of the NH2-terminal 
portion of the pEX5 region on the kinetics of actin polymer- 
ization, and was confirmed by native gel electrophoresis. 
There is some discrepancy between the affinity of the pEX5 
domain for G-actin as estimated from native gel electropho- 
resis, which is around 10  -~ M, and the ability of pEX5 to 
inhibit  pyrene-actin polymerization,  which  is  essentially 
complete when equimolar amounts of pEX5 are added. In 
addition, there is a somewhat greater inhibition of the initial 
rate of pyrene-actin polymerization at lower concentrations 
of pEX5 than would be expected. It is possible that the native 
gel assay substantially underestimates the Abl/G-actin affin- 
ity, perhaps because of instability of the complexes before or 
during electrophoretic separation.  It is  also possible that 
bundling or capping of short F-actin filaments by pEX5 dur- 
ing the initial stages of polymerization might exaggerate the 
effect which is observed, particularly at low concentrations 
of Abl; for example, see (Way et al., 1992). Careful kinetic 
measurements using the pEX5  and ASca(C) polypeptides 
may help resolve this question. 
This region ofpEX5 is quite proline rich (10/39 residues), 
but there is no similarity to a 20-amino acid conserved motif 
implicated in G-actin binding by several G-binding proteins 
such  as  gelsolin,  profilin,  and  cofilin  (Vandekerckhove, 
1989; Tellam et al., 1989).  A phosphorylation site for pro- 
tein kinase C is present adjacent to the proline-rich region 
(Pendergast et al., 1987), raising the possibility that a func- 
tion of this domain, such as G-actin binding or filament bun- 
dling,  might be  modulated by phosphorylation.  There  is 
precedent for this, as the actin filament cross-linking activity 
of the MARCKS protein is inhibited by phosphorylation by 
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preferentially to the ADP form of G-actin over ATP/G-actin. 
In this respect, Abl resembles gelsolin and profilin, which 
also preferentially bind ADP/G-actin (Laham et al.,  1993; 
Lal and Korn,  1985),  as opposed to fl4-thymosin,  which 
binds ATP/G-actin more tightly than ADP/G-actin (Carlier 
et al.,  1993).  Whether Abl influences ATPase activity or 
nucleotide exchange by actin monomers, as profilin and/~4- 
thymosin do (Goldschmidt-Clermont et al., 1992; Carlier et 
al., 1993),  is not known. Because newly depolymerized ac- 
tin is predominantly bound to ADP, while ATP/G-actin is 
preferentially incorporated at the barbed end of a growing 
actin filament, a protein such as Abl which preferentially 
binds ADP/G-actin might play a role in differential seques- 
tration of G-actin pools in the cell, spatially regulating fila- 
ment assembly. 
Together, the Abl F- and G-actin binding domains are able 
to bundle F-actin filaments in vitro (Fig. 4). This effect re- 
quires that both domains be present on the same polypeptide, 
and does not depend on the presence of GST sequences. The 
F-actin binding domain alone is unable to bundle actin. Bun- 
dling of F-actin requires that an actin-binding protein have 
multiple actin-binding domains (Matsudaira, 1991), or else 
be able to self-associate and form oligomers (Lynch et al., 
1987). In Abl, the combination of the two actin-binding do- 
mains appears to be sufficient for bundling, even though the 
G-actin binding domain alone shows no evidence of F-actin 
binding activity. It is possible that the combination of the two 
domains might result in an additional activity for actin. Gel- 
solin, for example, contains two G-actin binding domains 
and a  single F-actin binding domain (Bryan,  1988).  The 
combination of the three distinct actin-binding domains con- 
fers a new activity, F-actin severing, on the Gelsolin poly- 
peptide, which is not present in any of the individual do- 
mains. Alternatively, actin filaments will form bundles if 
their negative surface charge is neutralized either by >10 
mM Mg  2÷, by lower amounts of polycations such as polyly- 
sine or arginine pentamers, or even very low amounts of ba- 
sic peptides such as the 20-amino acid calmodulin-binding 
site of MARCKs (Hartwig et al., 1992). The pEX5 polypep- 
tide has a modest excess of basic amino acids, but the AFok 
polypeptide has essentially the same ratio of basic to acidic 
residues and lacks bundling activity, suggesting that specific 
cross-linking is more important for the induction of actin 
bundles by Abl than charge neutralization. 
Interaction of  Abl with the Cytoskeleton In Vivo 
We have shown that the F-actin binding domain of Abl is 
functional in vivo, but it is not known whether the G-actin 
binding and F-actin bundling activities are functional in the 
cell. Proteins with these activities can have disparate effects 
on the physiology of the actin cytoskeleton. G-actin binding 
proteins, such as/3,-thymosin, bind and sequester G-actin 
monomers within non-muscle cells, limiting the amount of 
actin available to participate in polymerization (Sanders and 
Wang, 1992). Actin-bundling proteins, such as fimbrin, con- 
tribute to the stability of the actin cytoskeleton and to the ul- 
trastructure of the cell, such as the microvillus of the intesti- 
nal epithelium (Matsudaira, 1983).  In the case of Abl, the 
G-actin binding/sequestering and F-actin binding/bundling 
activities would seem to be at odds with one another, with 
one inhibiting and the other promoting the formation of more 
complex actin structures.  Under in vitro conditions, bun- 
dling of F-actin by Abl appeared to predominate over disas- 
sembly.  Often,  the  actin-modulatory  functions  of actin- 
binding proteins are tightly controlled in the cell, as bundling 
and severing by gelsolin and villin are regulated by calcium 
and polyphosphoinositides (Matsudaira and Janmey, 1988). 
Hence, the net effect of the Abl actin-binding activities on 
the cytoskeleton may depend on local and spatial regulation 
of these activities within the cell, and on the presence and 
activity of other actin-modulatory proteins. 
However, a simple quantitative argument suggests that Abl 
is unlikely to play a major role in F-actin bundling or G-actin 
sequestration within the cell. Quantitation of Western blot 
experiments has indicated that NIH 3"1"3 cells contain about 
2.5  x  1@ Abl molecules per cell (P. Jackson, unpublished 
results), the majority of which may be nuclear. If there are 
2,500 stress fibers per cell on the average, there could be a 
maximum of about 100 Abl molecules per fiber, far less than 
the concentration of fimbrin in the microvillus (Glenny Jr. 
et al., 1981). In addition, the concentration of Abl in the cell 
would conservatively be predicted to be less than 1% of the 
G-actin pool. Although regional increases in the concentra- 
tion of Abl, such as those found in adhesion plaques, may 
permit the local cytoskeletal structure to be directly influ- 
enced by Abl, it is apparent that Abl is not a major cellular 
actin sequestering or bundling protein. 
Abl might also modulate the state of the cytoskeleton in- 
directly via a number of mechanisms. Although the tyrosine 
kinase activity of Abl is not required for F-actin binding, it 
is possible that actin itself or another associated protein is 
an important target for phosphorylation by Abl. It has been 
recently shown that tyrosine phosphorylation of a subset of 
actin in the  slime mold Dictyostelium is  associated with 
changes in cell morphology (Howard et al., 1993; Schweiger 
et al.,  1992).  A protein (3BP-1) has been identified which 
binds to the c-Abl SH3 domain and contains a region of ho- 
mology to the GTPase-activating protein (GAP) for p21 rh° 
(Cicchetti et al., 1992), and has recently been shown to func- 
tion as a GAP for Rho in vitro (Cicchetti, P., D. Baltimore, 
and R.  Cerione, unpublished results).  The association of 
Abl with the actin cytoskeleton may therefore serve to re- 
cruit Rho-GAP activity to the cytoskeleton via the Abl SH3 
domain, perhaps regulating some of the cytoskeletal effects 
mediated by Rho (Ridley and Hall,  1992). 
Abl may also use the dynamic cytoskeletal scaffolding to 
receive and transduce signals through a  direct or indirect 
mechanism. It has recently been demonstrated that strain 
can be transmitted to the F-actin cytoskeleton through the 
interaction  of integrins  with  their  cell-surface  receptors 
(Wang et al., 1993).  It is possible that actin-associated Abl 
might be able to sense this mechanical signal directly and re- 
spond by tyrosine phosphorylation of a downstream effector. 
Alternatively, Abl may respond to signals relayed by other 
cytoskeletal components. Because Abl contains nuclear lo- 
calization signals and a  DNA binding domain, it has the 
potential  to  transfer  signals  from  the  cell  surface  and 
cytoskeleton directly to the nucleus. Overexpression studies 
have shown the protein to be present at some level at plasma 
membrane,  cytoskeleton,  cytoplasm,  and  nucleus  in  all 
ceils, and there is as yet no evidence for movement of Abl 
between various compartments, save for the observation that 
all transforming Abl proteins are wholly cytoplasmic (Van 
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ing pattern of Abl will be essential to understanding  signal 
transduction  by this complex protein. 
The effect of actin binding on transformation  by activated 
forms of Abl is not clear-cut. The actin-binding domain ap- 
pears not to be required for fibroblast transformation  by acti- 
vated  forms of c-Abl,  because this domain can be deleted 
from p160  ~-abt or from the SH3-deleted c-Abl mutant AXB 
without an appreciable effect on transformation  efficiency 
(Prywes et al., 1985; Jackson and Baltimore, 1989; Jackson, 
P.,  unpublished  observations).  However,  McWhirter  and 
Wang found a small effect of deleting the actin-binding do- 
main on transformation  of Rat-1/v-myc cells or factor-depen- 
dent B-lymphoid ceils by the P210  ~r/~ protein (McWhirter 
and Wang,  1993). Bcr/Abl proteins are weaker transforming 
proteins than v-Abl, and it is possible that a modest depen- 
dence of transformation  on actin-association may be detected 
with these proteins when none is observed with activated 
c-Abl. 
The  large  90-kD  COOH-terminal  region  of  c-Abl  is 
unique to members of the Abl family and is not present in 
other members of the Src family.  It is now apparent that a 
major role of the Abl COOH terminus is to confer several 
novel localizing  functions upon the protein,  including  as- 
sociation with the actin cytoskeleton, signals for nuclear lo- 
calization, and a domain mediating binding to DNA (Kip- 
reos and Wang,  1992). The Abl COOH terminus appears to 
be essential for proper function of the protein during central 
nervous system development in Drosophila (Gertler et al., 
1989; Henkemeyer et al., 1990) and lymphoid development 
in mice (Schwartzberg et al., 1991; Tybulewicz et al., 1991). 
Although the precise role of these COOH-terminal functions 
in  the  physiology  of Abl  is  not  understood,  the  present 
studies offer the potential to directly examine the contribu- 
tion of the actin-binding domains in these and other genetic 
systems. 
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